文献速递淋巴瘤

中国儿童T细胞淋巴母细胞淋巴瘤的临床特征、突变图谱及其预后影响

Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T-cell lymphoblastic lymphoma.
PubMed 文献 · Br J Haematol · 2025-09-16

该研究纳入552例T细胞淋巴母细胞淋巴瘤(T-LBL)患儿,对其中119例肿瘤样本行262个淋巴瘤相关基因的靶向二代测序,分析突变与生存、复发及临床因素的关系。结果显示胸腔积液侵犯与无事件生存(EFS)和总生存(OS)不良显著相关(p<0.05);NOTCH1突变(44%)患者EFS和OS改善(p<0.01),而CREBBP、PTEN和LYST突变患者预后更差(p<0.05)。

要点

  • 胸腔积液侵犯与儿童T-LBL的EFS和OS不良显著相关(p<0.05)。
  • NOTCH1突变(44%)患者EFS和OS改善(p<0.01);CREBBP、PTEN、LYST突变者预后更差(p<0.05)。
  • 常见反复突变基因为NOTCH1(44%)、FBXW7(28%)、PHF6(11%)、KRAS(10%)、NRAS(10%)。

核心结论

  • 儿童T-LBL中NOTCH1突变与良好预后相关,CREBBP、PTEN和LYST突变及胸腔积液侵犯与不良预后相关。
  • 该研究识别了儿童T-LBL进展的关键分子和临床因素,有助于高危患者识别和个体化治疗策略。

研究设计与样本

  • 研究纳入552例患者,对其中119例患者的肿瘤样本行262个淋巴瘤相关基因的靶向二代测序。
  • 分析突变与生存率、复发及其他临床因素之间的关联。

主要发现

  • 胸腔积液侵犯与无事件生存(EFS)和总生存(OS)不良显著相关(p<0.05)。
  • 共识别92个反复突变基因,最常见为NOTCH1(44%)、FBXW7(28%)、PHF6(11%)、KRAS(10%)和NRAS(10%)。
  • NOTCH1突变患者EFS和OS改善(p<0.01)。
  • 携带CREBBP、PTEN和LYST突变的患者预后更差(p<0.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

T-cell lymphoblastic lymphoma (T-LBL) is an aggressive lymphoma that primarily affects children and young adults, and a comprehensive understanding of its molecular features is crucial for improving patient outcomes. In this study, 552 patients were included, with targeted next-generation sequencing of 262 lymphoma-associated genes performed on tumour samples from 119 patients. The associations between mutations and survival rates, as well as relapse and other clinical factors, were analysed. The results demonstrated that pleural effusion (PE) invasion was significantly associated with adverse event-free survival (EFS) and overall survival (OS) (p < 0.05). Additionally, we identified 92 genes with recurrent mutations, among which NOTCH1 (44%), FBXW7 (28%), PHF6 (11%), KRAS (10%) and NRAS (10%) were the most frequently altered. Patients with NOTCH1 mutations exhibited improved EFS and OS (p < 0.01), whereas those carrying CREBBP, PTEN and LYST mutations exhibited worse prognosis (p < 0.05). In conclusion, NOTCH1 mutations are associated with a favourable prognosis in paediatric T-LBL, while CREBBP, PTEN and LYST mutations, as well as PE invasion, are linked to poor prognosis. This study identifies key molecular and clinical factors in paediatric T-LBL progression, aiding high-risk patient identification and personalized treatment strategies.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Li Y, Jin L, Liu W, et al. Clinical features, mutational landscape and their prognostic impact in Chinese paediatric patients with T-cell lymphoblastic lymphoma. Br J Haematol. 2025. PMID: 40958529. doi:10.1111/bjh.70097

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。